Diagnos Laboratorium Utama PT Tbk Total Liabilities

Latest as of June 2025: Rp110.07 Billion IDR ≈ $6.45 Million USD

Diagnos Laboratorium Utama PT Tbk total liabilities. Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has total liabilities worth Rp110.07 Billion IDR (≈ $6.45 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Diagnos Laboratorium Utama PT Tbk liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Diagnos Laboratorium Utama PT Tbk (2017–2024)

Total liabilities of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024. This chart illustrates how Diagnos Laboratorium Utama PT Tbk's total liabilities have evolved over time, based on quarterly financial data.

Diagnos Laboratorium Utama PT Tbk Competitors by Total Liabilities

The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their total liabilities.

Company	Country	Total Liabilities
Manaksia Aluminium Company Limited NSE:MANAKALUCO	India	Rs3.96 Billion
Plantynet Co. Ltd KQ:075130	Korea	₩13.74 Billion
Personal Assets Trust plc LSE:PNL	UK	GBX4.02 Million
Alpha Exploration Ltd V:ALEX	Canada	CA$395.82K
9F Inc NASDAQ:JFU	USA	$537.09 Million
Korean Drug Co. Ltd KQ:014570	Korea	₩20.08 Billion
Sidiz Inc KO:134790	Korea	₩32.22 Billion
Allied Industrial Ltd TWO:4702	Taiwan	NT$218.53 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Diagnos Laboratorium Utama PT Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Diagnos Laboratorium Utama PT Tbk assets under control.

Liquidity & Leverage Metrics

Diagnos Laboratorium Utama PT Tbk Total Liabilities Ratios Explained

Diagnos Laboratorium Utama PT Tbk total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.57	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Diagnos Laboratorium Utama PT Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Diagnos Laboratorium Utama PT Tbk (2017–2024)

The table below shows the annual total liabilities of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	Rp103.89 Billion ≈ $6.09 Million	+36.91%
2023-12-31	Rp75.88 Billion ≈ $4.45 Million	+157.17%
2022-12-31	Rp29.51 Billion ≈ $1.73 Million	-26.57%
2021-12-31	Rp40.18 Billion ≈ $2.35 Million	+19.92%
2020-12-31	Rp33.51 Billion ≈ $1.96 Million	+162.55%
2019-12-31	Rp12.76 Billion ≈ $747.85K	+14.23%
2018-12-31	Rp11.17 Billion ≈ $654.69K	+112.02%
2017-12-31	Rp5.27 Billion ≈ $308.79K	--

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$20.66 Million

Rp352.50 Billion IDR

Market Cap Rank

#24841 Global

#517 in Indonesia

Share Price

Rp282.00

Change (1 day)

-6.00%

52-Week Range

Rp142.00 - Rp328.00

All Time High

Rp1408.74